Kyverna Therapeutics, Inc. Shares Outstanding (Cover Page)
Kyverna Therapeutics, Inc. (KYTX) had Shares Outstanding (Cover Page) of 61.84 million shares as of 2026-08-03, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-03: Entity Common Stock, Shares Outstanding 61.84M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 60.80M shares.
- 2026-03-01: Entity Common Stock, Shares Outstanding 60.44M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 43.80M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 61.84M shares 10-Q · filed 2026-08-11 |
| 2026-05-01 | 60.80M shares 10-Q · filed 2026-05-12 |
| 2026-03-01 | 60.44M shares 10-K · filed 2026-03-26 |
| 2025-10-31 | 43.80M shares 10-Q · filed 2025-11-12 |
| 2025-08-04 | 43.25M shares 10-Q · filed 2025-08-12 |
| 2025-05-01 | 43.22M shares 10-Q · filed 2025-05-13 |
| 2025-03-01 | 43.21M shares 10-K · filed 2025-03-27 |
| 2024-10-31 | 43.17M shares 10-Q · filed 2024-11-13 |
| 2024-07-31 | 43.15M shares 10-Q · filed 2024-08-12 |
| 2024-05-10 | 43.12M shares 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |